Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice-Reference-Cited by-同舟云学术

Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice

Published:2022-07-06 Issue: Volume: Page:1-10
ISSN:1365-1501
Container-title:International Journal of Psychiatry in Clinical Practice
language:en
Short-container-title:International Journal of Psychiatry in Clinical Practice

Author:

Fraguas David¹,Almenta Gallego David²,Arques-Egea Sergio³,Gómez-Revuelta Marcos⁴,Sánchez-Lafuente Carlos Gómez⁵^ORCID,Hernández Huerta Daniel⁶,Núñez Arias Daniel⁷,Oda Plasencia-García Beatriz⁸,Parro Torres Carlos⁹^ORCID,Romero-Guillena Samuel Leopoldo¹⁰,Ros Cucurul Elena¹¹^ORCID,Alamo Cecilio¹²

Affiliation:

1. Institute of Psychiatry and Mental Health, Hospital Clínico San Carlos, IdISSC, CIBERSAM, School of Medicine (UCM), Madrid, Spain

2. Department of Psychiatry, Santa Creu and Sant Pau Hospital, Barcelona, Spain

3. Paterna’s Mental Health Service, Arnau de Vilanova-Lliria University Hospital, Valencia, Spain

4. Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, University of Cantabria, Santander, Spain

5. Mental Health’s Clinical Management Service, Malaga University Hospital, Málaga, Spain

6. Department of Psychiatry, Ramón y Cajal University Hospital, Madrid, Spain

7. Department of Psychiatry, Ferrol Hospital, A Coruña, Spain

8. Department of Psychiatry, Mental Health’s Clinical Management Service, Virgen del Rocio University Hospital, Sevilla, Spain

9. Institute of Psychiatry and Mental Health, Gregorio Marañón University General Hospital, Madrid, Spain

10. Department of Psychiatry, UGC Mental Health, Macarena Hospital, Sevilla, Spain

11. Department of Psychiatry, Vall d'Hebron University Hospital, CIBERSAM, Autonomous University of Barcelona, Barcelona, Spain

12. Department of Biomedicine, Alcala de Henares, University, Madrid, Spain

Funder

Otsuka-Lundbeck alliance

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/13651501.2022.2064308

Reference48 articles.

1. Medication adherence in schizophrenia

2. Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies

3. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus

4. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first‐episode psychosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–drug interaction and initial dosage optimization of aripiprazole in patients with schizophrenia based on population pharmacokinetics;Frontiers in Psychiatry;2024-06-18

2. Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients;Neuropsychiatric Disease and Treatment;2024-03

3. Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review;International Journal of Psychiatry in Clinical Practice;2023-07-10

4. Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations;Expert Opinion on Drug Metabolism & Toxicology;2023-04-03